Efficacy and quality of life outcomes in patients with advanced melanoma (MEL) who discontinued treatment with nivolumab (NIVO) plus ipilimumab (IPI) due to toxicity in a phase 3 trial (CheckMate 067) Meeting Abstract
| Authors: | Schadendorf, D.; Larkin, J.; Chiarion-Sileni, V.; Gonzalez, R.; Rutkowski, P.; Grob, J. J.; Cowey, C. L.; Lao, C.; Taylor, F.; Sabater, J.; Walker, D.; Bhore, R.; Wolchok, J.; Hodi, F. S. |
| Abstract Title: | Efficacy and quality of life outcomes in patients with advanced melanoma (MEL) who discontinued treatment with nivolumab (NIVO) plus ipilimumab (IPI) due to toxicity in a phase 3 trial (CheckMate 067) |
| Meeting Title: | 16th World Congress on Cancers of the Skin (WCCS) |
| Journal Title: | Melanoma Research |
| Volume: | 26 |
| Issue: | e-Suppl. |
| Meeting Dates: | 2016 Aug 31-Sep 3 |
| Meeting Location: | Vienna, Austria |
| ISSN: | 0960-8931 |
| Publisher: | Lippincott Williams & Wilkins |
| Date Published: | 2016-08-01 |
| Start Page: | e4 |
| Language: | English |
| ACCESSION: | WOS:000383560800006 |
| PROVIDER: | wos |
| DOI: | 10.1097/CMR.0000000000000285 |
| Notes: | Meeting Abstract: SY12-4 -- Source: Wos |
